{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:40:06Z","timestamp":1756284006507,"version":"3.44.0"},"reference-count":4,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Review of:<\/jats:bold> Aroniadis OC, Brandt LJ, Oneto C, <jats:italic>et al<\/jats:italic>. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. <jats:italic>Lancet Gastroenterol Hepatol<\/jats:italic> 2019;4:675\u201385.<\/jats:p>","DOI":"10.1136\/dtb.2020.000013","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T17:15:36Z","timestamp":1583946936000},"page":"87-87","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["No benefit of faecal microbiota transplantation for IBS-D"],"prefix":"10.1136","volume":"58","member":"239","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2025082701210034000_58.6.87.1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2468-1253(19)30198-0","article-title":"Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial","volume":"4","author":"Aroniadis","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025082701210034000_58.6.87.2","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2014.12.0298"},{"key":"2025082701210034000_58.6.87.3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012774.pub2"},{"key":"2025082701210034000_58.6.87.4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2020.000013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:21:10Z","timestamp":1756282870000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2020.000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":4,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,5,27]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/dtb.2020.000013"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2020.000013","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2020,3,11]]}}}